STOCK TITAN

Biotricity Inc - BTCY STOCK NEWS

Welcome to our dedicated page for Biotricity news (Ticker: BTCY), a resource for investors and traders seeking the latest updates and insights on Biotricity stock.

Biotricity, Inc. (BTCY) is a medical technology company at the forefront of healthcare innovation. Specializing in biometric data monitoring solutions, Biotricity aims to improve healthcare by developing remote monitoring solutions for chronic disease prevention and management. Its premier product, Bioflux, is an ECG monitoring system used by physicians to diagnose and monitor cardiac patients remotely. Biotricity's Biolife solution extends medical-grade monitoring to the consumer market, empowering users to self-manage chronic conditions through lifestyle changes. With a focus on preventive healthcare, Biotricity's R&D efforts aim to put health management directly into the hands of individuals, easing the burden on the healthcare system.

Rhea-AI Summary
Biotricity Inc. reports robust performance improvements and record Q1-FY2024 recurring revenue growth. The company has achieved higher margins on technology fees and has strong control over sales and technology expenses through automation and AI.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.49%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.09%
Tags
AI
-
Rhea-AI Summary
Biotricity strengthens relationships with Amazon and Google to expand its AI technology development in remote cardiac care. The company has built a powerful proprietary cardiac AI model that combines Google's TensorFlow, AWS infrastructure, big data, and a continuous learning engine. This technology allows for improved patient care, increased sales of remote cardiac monitoring devices, and accelerated recurring revenue. Biotricity's suite of products addresses the growing market for remote patient monitoring and aims to improve healthcare efficiency.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.58%
Tags
AI
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.67%
Tags
none
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.54%
Tags
-
News
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.75%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.8%
Tags
conferences earnings
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.48%
Tags
AI
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.8%
Tags
none

FAQ

What is the current stock price of Biotricity (BTCY)?

The current stock price of Biotricity (BTCY) is $0.645 as of February 21, 2025.

What is the market cap of Biotricity (BTCY)?

The market cap of Biotricity (BTCY) is approximately 14.3M.

What is Biotricity, Inc.?

Biotricity, Inc. is a medical technology company focused on developing biometric data monitoring solutions for chronic disease prevention and management.

What are some of Biotricity's products?

Biotricity's premier product is Bioflux, an ECG monitoring system used for diagnosing and remotely monitoring cardiac patients. The company also offers Biolife, a consumer-focused solution for self-managing chronic conditions.

What is the vision of Biotricity, Inc.?

Biotricity aims to empower individuals by providing innovative solutions for preventive healthcare, ultimately enabling users to take control of their health and manage critical conditions effectively.

How does Biotricity contribute to the healthcare industry?

Biotricity's focus on remote monitoring and chronic care management bridges the gap in healthcare services, offering diagnostic and post-diagnostic solutions for chronic conditions, particularly in the cardiology sector.
Biotricity Inc

Nasdaq:BTCY

BTCY Rankings

BTCY Stock Data

14.29M
14.43M
40.89%
0.43%
2.07%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States
REDWOOD CITY